BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16607077)

  • 1. Interleukin-6 -174 G/C promoter polymorphism and effects of fenofibrate and simvastatin on inflammatory markers in hypercholesterolemic patients.
    Potaczek DP; Undas A; Celinska-Lowenhoff M; Szczeklik A
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):35-8. PubMed ID: 16607077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
    J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients.
    Rosenson RS
    Obesity (Silver Spring); 2009 Mar; 17(3):504-9. PubMed ID: 19023279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men.
    Chiappelli M; Tampieri C; Tumini E; Porcellini E; Caldarera CM; Nanni S; Branzi A; Lio D; Caruso M; Hoffmann E; Caruso C; Licastro F
    Int J Immunogenet; 2005 Dec; 32(6):349-53. PubMed ID: 16313298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
    Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 6 G-174C polymorphism influences outcome following coronary revascularization surgery.
    Bittar MN; Carey JA; Barnard J; Fildes JE; Pravica V; Yonan N; Hutchinson IV
    Heart Surg Forum; 2005; 8(3):E140-5; discussion E145. PubMed ID: 16183563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.
    Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus.
    Hiukka A; Westerbacka J; Leinonen ES; Watanabe H; Wiklund O; Hulten LM; Salonen JT; Tuomainen TP; Yki-Järvinen H; Keech AC; Taskinen MR
    J Am Coll Cardiol; 2008 Dec; 52(25):2190-7. PubMed ID: 19095138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between inflammatory markers and the interleukin-6 -174 G/C polymorphism is abolished in peripheral arterial occlusive disease.
    Potaczek DP; Undas A; Nowakowski T; Szczeklik A
    Int Angiol; 2007 Dec; 26(4):318-23. PubMed ID: 18091699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris.
    Ozdemir O; Gundogdu F; Karakelleoglu S; Sevimli S; Pirim I; Acikel M; Arslan S; Serdar S
    Coron Artery Dis; 2008 Feb; 19(1):15-9. PubMed ID: 18281810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 g.-174G>C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study.
    Klipstein-Grobusch K; Möhlig M; Spranger J; Hoffmann K; Rodrigues FU; Sharma AM; Klaus S; Pfeiffer AF; Boeing H
    Obesity (Silver Spring); 2006 Jan; 14(1):14-8. PubMed ID: 16493118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in interleukin-6 following arterial injury is related to insulin resistance, the -174G-->C polymorphism and complex plaque morphology.
    Marso SP; House JA; Hopkins PJ
    Int J Immunogenet; 2006 Oct; 33(5):347-54. PubMed ID: 16984279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6 and interleukin-6 promoter polymorphism (-174) G > C in patients with spontaneous venous thromboembolism.
    Vormittag R; Hsieh K; Kaider A; Minar E; Bialonczyk C; Hirschl M; Mannhalter C; Pabinger I
    Thromb Haemost; 2006 May; 95(5):802-6. PubMed ID: 16676071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis.
    Sie MP; Sayed-Tabatabaei FA; Oei HH; Uitterlinden AG; Pols HA; Hofman A; van Duijn CM; Witteman JC
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):212-7. PubMed ID: 16269662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between soluble P-selectin and inflammatory factors (interleukin-6 and C-reactive protein) in colorectal cancer.
    Dymicka-Piekarska V; Matowicka-Karna J; Gryko M; Kemona-Chetnik I; Kemona H
    Thromb Res; 2007; 120(4):585-90. PubMed ID: 17169411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The -174 G/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian population.
    Pola R; Flex A; Gaetani E; Pola P; Bernabei R
    J Hum Hypertens; 2002 Sep; 16(9):637-40. PubMed ID: 12214260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. -174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer.
    Belluco C; Olivieri F; Bonafè M; Giovagnetti S; Mammano E; Scalerta R; Ambrosi A; Franceschi C; Nitti D; Lise M
    Clin Cancer Res; 2003 Jun; 9(6):2173-6. PubMed ID: 12796383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced interleukin-1beta in hypercholesterolemia: effects of simvastatin and low-dose aspirin.
    Ferroni P; Martini F; Cardarello CM; Gazzaniga PP; Davi G; Basili S
    Circulation; 2003 Oct; 108(14):1673-5. PubMed ID: 14504184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutraceutical strategy in aging: targeting heat shock protein and inflammatory profile through understanding interleukin-6 polymorphism.
    Marotta F; Koike K; Lorenzetti A; Naito Y; Fayet F; Shimizu H; Marandola P
    Ann N Y Acad Sci; 2007 Nov; 1119():196-202. PubMed ID: 18056967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension.
    Wong LY; Leung RY; Ong KL; Cheung BM
    J Hum Hypertens; 2007 Nov; 21(11):875-82. PubMed ID: 17508011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.